Your Location:
Home >
Browse articles >
Exploring Potential Biomarkers of Blood Stasis Syndrome in Coronary Heart Disease and Association Between Platelet Metabolic Disorder and Myocardial Injury Based on Platelet Metabolomics
Exploring Potential Biomarkers of Blood Stasis Syndrome in Coronary Heart Disease and Association Between Platelet Metabolic Disorder and Myocardial Injury Based on Platelet Metabolomics
Enhanced Publication- “UPLC-Q-Exactive Orbitrap-MS technology revealed the mechanism of platelet metabolism disorder in rats with coronary heart disease and blood stasis syndrome. The sum of four metabolite curves reached 1.0, opening up new directions for disease diagnostic biomarker screening and pathological research.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 17, Pages: 239-247(2026)
DOI: 10.13422/j.cnki.syfjx.20260661
Revised:2026-05-24 ,
Accepted:01 June 2026
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 1 )
References
Publication Info
Metrics
141
Views
79
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Xuefu Zhuyutang Treats Coronary Heart Disease with Blood Stasis Syndrome in Rats via SIRT3 Signaling Pathway-mediated Regulation of Endothelial Function
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics
Platelet Metabolomics Analysis in Rats of Coronary Heart Disease with Blood Stasis Syndrome by Overexpression of Fibrinogen
Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway
Tangbikang Granules Improve Diabetic Peripheral Neuropathy by Inhibiting Ferroptosis via AMPK/Nrf2 Signaling Pathway
Related Author
YAN Qing
YU Yonghong
TIAN Peng
SU Chang
LIANG Hao
YANG Yang
PENG Qinghua
ZHANG Qiuyan
Related Institution
Hunan University of Chinese Medicine
Hunan Provincial Center for Drug Evaluation and Adverse Drug Reaction Monitoring
School of Clinical Medicine,Beijing University of Chinese Medicine
Beijing Key Laboratory of Chinese Materia Pharmacology,National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases,Institute of Basic Medical Sciences, Xiyuan Hospital,China Academy of Chinese Medical Sciences
Natural History Museum of China


